Subscribe

DOI:

EAPCI Focus on “Hot topics in Interventional Cardiology” at ESC 2016

EAPCI Focus on “Hot topics in Interventional Cardiology” at ESC 2016

This year’s European Society of Cardiology congress in Rome highlights 163 specific topics organised under nine main subject areas organised in themed villages.

The EAPCI has specifically organised Village 2, with the following subthemes: interventions / peripheral circulation / stroke / surgery.

The objectives of these Village 2 presentations are to combine the latest research with case presentations and interactive discussions to provide clear-cut, simple, take-home messages for the practising clinician – something that they can use right away in the daily care of their patients.

There will also be a focus on the Heart Team, with discussions on the expansion of the “Team” beyond interventional cardiologists and cardiac surgeons to all related professionals, including general cardiologists, general practitioners and endocrinologists, etc.

Other topics of interest include: blood thinning following transaortic valve implantation (TAVI); bystander lesions in ST-segment elevation myocardial infarction (STEMI); managing multiple, multi-state diseases; balancing ischaemia management with bleeding risk and translating recommendations into individual care (the 2015 non-STEMI ESC clinical practice guidelines).

In addition, there will be a special session entitled: “Hot topics in Interventional Cardiology”. This will take place on the 30th of August from 14:00 to 15:30, “Helsinki” (Village 2) under the chairmanship of Marco Valgimigli (Bern, Switzerland) and Andreas Baumbach (Bristol, United Kingdom).

In the field of percutaneous valvular interventions, Stephan Windecker (Bern, Switzerland) will discuss whether TAVI will replace surgical aortic valve replacement and Michael Haude, President of the EAPCI (Neuss, Germany), will present transcatheter mitral valve repair and replacement techniques. In the field of coronary interventions, Robert Byrne (Munich, Germany) will present a critical appraisal of the first-generation bioresorbable coronary scaffold devices. Felix Mahfoud (Homburg/Saar, Germany) will update the attendees on renal denervation for the treatment of arterial hypertension.

For more information check out www.escardio.org

NEWS

Save the date! EAPCI General Assembly at ESC Congress

All ESC Associations have aligned their constitutions with ESC Statutes to facilitate internal governance. EAPCI Members are invited to vote on the new EAPCI Constitution during the General Assembly taking place during ESC Congress 2016 in Rome on Sunday 28 August 2016 from 15:00 to 15:30, Passarella, Level 1, ESC Meeting Room 5.

The EAPCI now has more than 7,400 members from 133 countries! Join today and be part of an interactive European interventional cardiology network. EAPCI Membership is free and offers a wide range of benefits.

Mark your calendar! Applications for EAPCI interventional cardiology training and research grants open in September 2016. For more info: www.escardio.org/eapci

Volume 12 Number 6
Aug 20, 2016
Volume 12 Number 6
View full issue


Key metrics

Trending articles
69.996

10.4244/EIJV13I12A217 Dec 8, 2017
Swimming against the tide: insights from the ORBITA trial
Al-Lamee R and Francis D
free
59.65

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
57.6

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
38.75

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
15.85

State-of-the-Art

10.4244/EIJ-D-23-01050 Jul 15, 2024
Durability of transcatheter aortic valve implantation
Ternacle J et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
How have techniques for transcatheter mitral valve repair and replacement evolved?
What outcomes have studies shown for first-generation bioresorbable scaffold devices?
What is the evidence for using renal denervation to treat hypertension?
What clinical guidance will be provided on managing patients with multiple cardiovascular conditions?
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved